Literature DB >> 8738300

In vivo evidence for the involvement of tachykinin NK3 receptors in the hexamethonium-resistant inhibitory transmission in the rat colon.

A Lecci1, S Giuliani, M Tramontana, S Meini, R De Giorgio, C A Maggi.   

Abstract

In urethane-anaesthetized rats, moderate colonic distention (0.5 ml) induced reflex rhythmic contractions (5 mm Hg amplitude and 1.1 cycles/min frequency). Senktide (1-10 nmol/kg, i.v.), a tachykinin NK3 receptor selective agonist, transiently suppressed distension-induced contractions. SR 142,801 (1-10 mumol/kg i.v.), a non-peptide tachykinin NK3 receptor antagonist, had no effect on distension-induced contractions but prevented the inhibitory effect of senktide. Infusion of N-omega-nitro-1-arginine methyl esther hydrochloride (L-NAME, 20 mumol/ml/h, i.v) increased the amplitude of colonic contractions and decreased the inhibitory effect of senktide. Hexamethonium (15 mumol/ml/h, i.v.) or atropine (1 mumol/ml/h, i.v.) inhibited the distension-induced contractions. In hexamethonium- or atropine-treated rats, senktide (10 nmol/kg) transiently and selectively enhanced the amplitude of contractions. Also SR 142,801 (10 mumol/kg), but not its inactive enantiomer SR 142,806, increased both amplitude and frequency of contractions. During continuous infusion of L-NAME and hexamethonium or atropine both frequency and amplitude of distension-induced colonic contractions were higher than when in hexamethonium or atropine only. Senktide (10 nmol/kg) had no effect and SR 142,801 (10 mumol/kg) produced a slight enhancement of colonic contractions. Infusion of sodium nitroprusside (3 mumol/ml/h, i.v.) decreased amplitude and frequency of distension-induced contractions. SR 142,801 had no effect in the presence of the nitric oxide (NO) donor. We conclude that tachykinins acting through NK3 receptors exert at least four different actions on colonic motility activated by distension: 1) a hexamethonium-resistant, NO-dependent, suppressant effect on contractions; 2) a hexamethonium-sensitive, NO-independent inhibitory effect on the amplitude of contractions; 3) a hexamethonium-resistant, NO-independent inhibitory effect on the amplitude of contractions and 4) a hexamethonium resistant and L-NAME-sensitive excitatory effect on amplitude of contractions. The prevalent inhibitory effect evoked in normal conditions along with the excitatory activity induced by SR 142,801 on hexamethonium-resistant colonic motility indicates that tachykinins, acting through neuronal NK3 receptors, activate NO-dependent and NO-independent inhibitory neurotransmission in the rat colon.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738300     DOI: 10.1007/bf00167186

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  Effect of SR 142801 on nitric oxide-dependent and independent responses to tachykinin NK3 receptor agonists in isolated guinea-pig colon.

Authors:  S Giuliani; C A Maggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

2.  SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor.

Authors:  X Emonds-Alt; D Bichon; J P Ducoux; M Heaulme; B Miloux; M Poncelet; V Proietto; D Van Broeck; P Vilain; G Neliat
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

3.  Occurrence, release, and effects of multiple tachykinins in cat colonic tissues and nerves.

Authors:  P M Hellström; O Söder; E Theodorsson
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

4.  Functional difference between SP and NKA: relaxation of gastric muscle by SP is mediated by VIP and NO.

Authors:  J G Jin; S Misra; J R Grider; G M Makhlouf
Journal:  Am J Physiol       Date:  1993-04

5.  Nitric oxide is the mediator of tachykinin NK3 receptor-induced relaxation in the circular muscle of the guinea-pig ileum.

Authors:  C A Maggi; R Patacchini; S Meini; S Giuliani
Journal:  Eur J Pharmacol       Date:  1993-08-10       Impact factor: 4.432

6.  Neurokinin3 receptor regulation of acetylcholine release from myenteric plexus.

Authors:  W M Yau; K G Mandel; J A Dorsett; M L Youther
Journal:  Am J Physiol       Date:  1992-11

7.  Neurokinin B is a preferred agonist for a neuronal substance P receptor and its action is antagonized by enkephalin.

Authors:  R Laufer; U Wormser; Z Y Friedman; C Gilon; M Chorev; Z Selinger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

8.  Evidence for neurokinin-3 receptor-mediated tachykinin release in the guinea-pig ileum.

Authors:  S Guard; S P Watson
Journal:  Eur J Pharmacol       Date:  1987-12-15       Impact factor: 4.432

9.  Nitric oxide causes contraction in the rat isolated small intestine.

Authors:  L Barthó; R A Lefebvre
Journal:  Eur J Pharmacol       Date:  1994-06-23       Impact factor: 4.432

10.  Highly selective agonists for substance P receptor subtypes.

Authors:  U Wormser; R Laufer; Y Hart; M Chorev; C Gilon; Z Selinger
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  2 in total

1.  Differential role of tachykinin NK3 receptors on cholinergic excitatory neurotransmission in the mouse stomach and small intestine.

Authors:  J G De Man; B Y De Winter; H U De Schepper; A G Herman; P A Pelckmans
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

Review 2.  Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain.

Authors:  Gareth J Sanger
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.